Filing Details
- Accession Number:
- 0000899243-22-013963
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-05 21:14:46
- Reporting Period:
- 2022-04-01
- Accepted Time:
- 2022-04-05 21:14:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1665988 | Bioventus Inc. | BVS | Surgical & Medical Instruments & Apparatus (3841) | 810980861 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1835973 | John Nosenzo | 4721 Emperor Boulevard, Suite 100 Durham NC 27703 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2022-04-01 | 106,485 | $0.00 | 149,895 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2022-04-04 | 65,963 | $11.12 | 83,932 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Restricted Stock Units | Disposition | 2022-04-01 | 106,485 | $0.00 | 106,485 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- Includes 40 shares acquired under the Company's 2021 Employee Stock Purchase Program on April 1, 2022.
- Reflects shares sold to cover taxes upon the vesting of RSUs on April 1, 2022 pursuant to a standing 10b5-1 instruction.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.48, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The RSUs vested on April 1, 2022.
Billionaire Hedge Funds
